Advocacy and Thought Leadership

The George Institute is focused on effective advocacy and thought leadership to improve health, aligned to our research goals.

We are engaging with key stakeholders, sharing insights and fostering discussions to stimulate debate, guide critical health policy decisions and facilitate evidence-based change.

By working with some of the world’s leading health voices we are amplifying our work in non-communicable diseases (NCDs) and injury and improving systems for prevention and treatment.

Our activities

The George Institute for Global Health invites you to its next webinar in the 'Tea with Africa' conversation series on “Global Surgery: History, Current Directions and Future Opportunities” on …
Event
On International Day of the Girl, Claudia Selin Batz (Policy and Advocacy Advisor, The George Institute) and Kayla Arnold (Policy Advisor, Age International) reflect on the outcomes of the UN High…
News
People need and want information to help them choose more sustainable food options. The food system is a significant contributor to greenhouse gas emissions, yet there is little reliable information…
Event
We are pleased to advise that The George Institute for Global Health submitted a proposal to the National Robotic Strategy in April 2023. Our submission focuses on harnessing the potential of…
Policy and Practice Reports
Research is underway in Fiji to inform policy makers about the need to implement new food policy and strengthen existing policies aimed at reducing diet-related illness, linked to excess salt, fat…
Landing Page
Ahead of World Lung Day (September 25th) Dr Anthony Sunjaya and the Respiratory Division has developed some new resources to help people understand more about breathlessness. Breathlessness is a…
News
In the last four years, the world has experienced multiple crises. The COVID-19 pandemic, climate crisis, conflict, food insecurity and rising cost of living have strained the resilience of our…
Policy and Practice Reports
The George Institute will be hosting a stakeholder meeting on September 5th to discuss the forthcoming WHO guidance for best practices for clinical trials. Are you planning to engage with the public…
Event
Psychedelic drugs, like psilocybin and MDMA, have captivated global interest for their potential in treating mental health disorders. While Australia has become the first country in the world to…
Podcast
Jointly organised by the Centre for Health Economics & Policy Innovation at Imperial College London, The George Institute for Global Health UK, and the Saw Swee Hock School of Public Health,…
Event